These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10834725)

  • 1. Hyperlactatemia, increased osmolar gap, and renal dysfunction during continuous lorazepam infusion.
    Reynolds HN; Teiken P; Regan ME; Habashi NM; Cottingham C; McCunn M; Scalea TM
    Crit Care Med; 2000 May; 28(5):1631-4. PubMed ID: 10834725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osmol gap as a surrogate marker for serum propylene glycol concentrations in patients receiving lorazepam for sedation.
    Barnes BJ; Gerst C; Smith JR; Terrell AR; Mullins ME
    Pharmacotherapy; 2006 Jan; 26(1):23-33. PubMed ID: 16422667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propylene glycol-associated renal toxicity from lorazepam infusion.
    Yaucher NE; Fish JT; Smith HW; Wells JA
    Pharmacotherapy; 2003 Sep; 23(9):1094-9. PubMed ID: 14524641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propylene glycol-induced lactic acidosis in a patient with normal renal function: a proposed mechanism and monitoring recommendations.
    Neale BW; Mesler EL; Young M; Rebuck JA; Weise WJ
    Ann Pharmacother; 2005 Oct; 39(10):1732-6. PubMed ID: 16159998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propylene glycol accumulation associated with continuous infusion of lorazepam in pediatric intensive care patients.
    Chicella M; Jansen P; Parthiban A; Marlowe KF; Bencsath FA; Krueger KP; Boerth R
    Crit Care Med; 2002 Dec; 30(12):2752-6. PubMed ID: 12483068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of continuous infusion lorazepam to serum propylene glycol concentration in critically ill adults.
    Arroliga AC; Shehab N; McCarthy K; Gonzales JP
    Crit Care Med; 2004 Aug; 32(8):1709-14. PubMed ID: 15286548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Propylene glycol accumulation in critically ill patients receiving continuous intravenous lorazepam infusions.
    Horinek EL; Kiser TH; Fish DN; MacLaren R
    Ann Pharmacother; 2009 Dec; 43(12):1964-71. PubMed ID: 19920159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute kidney injury, hyperosmolality and metabolic acidosis associated with lorazepam.
    Zar T; Yusufzai I; Sullivan A; Graeber C
    Nat Clin Pract Nephrol; 2007 Sep; 3(9):515-20. PubMed ID: 17717564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe lactic acidosis after an iatrogenic propylene glycol overdose.
    Zosel A; Egelhoff E; Heard K
    Pharmacotherapy; 2010 Feb; 30(2):219. PubMed ID: 20099997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Removal of propylene glycol and correction of increased osmolar gap by hemodialysis in a patient on high dose lorazepam infusion therapy.
    Parker MG; Fraser GL; Watson DM; Riker RR
    Intensive Care Med; 2002 Jan; 28(1):81-4. PubMed ID: 11819005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of a lorazepam dose threshold for using the osmol gap to monitor for propylene glycol toxicity.
    Yahwak JA; Riker RR; Fraser GL; Subak-Sharpe S
    Pharmacotherapy; 2008 Aug; 28(8):984-91. PubMed ID: 18657015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osmolar gap metabolic acidosis in a 60-year-old man treated for hypoxemic respiratory failure.
    Arbour R; Esparis B
    Chest; 2000 Aug; 118(2):545-6. PubMed ID: 10936154
    [No Abstract]   [Full Text] [Related]  

  • 13. Short-term lorazepam infusion and concern for propylene glycol toxicity: case report and review.
    Cawley MJ
    Pharmacotherapy; 2001 Sep; 21(9):1140-4. PubMed ID: 11560204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperosmolar metabolic acidosis and intravenous Lorazepam.
    Mullins ME; Barnes BJ
    N Engl J Med; 2002 Sep; 347(11):857-8; author reply 857-8. PubMed ID: 12226165
    [No Abstract]   [Full Text] [Related]  

  • 15. Propylene glycol toxicity: a severe iatrogenic illness in ICU patients receiving IV benzodiazepines: a case series and prospective, observational pilot study.
    Wilson KC; Reardon C; Theodore AC; Farber HW
    Chest; 2005 Sep; 128(3):1674-81. PubMed ID: 16162774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous infusions of lorazepam, midazolam, and propofol for sedation of the critically ill surgery trauma patient: a prospective, randomized comparison.
    McCollam JS; O'Neil MG; Norcross ED; Byrne TK; Reeves ST
    Crit Care Med; 1999 Nov; 27(11):2454-8. PubMed ID: 10579264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propylene glycol toxicity related to high-dose lorazepam infusion: case report and discussion.
    Arbour RB
    Am J Crit Care; 1999 Jan; 8(1):499-506. PubMed ID: 9987548
    [No Abstract]   [Full Text] [Related]  

  • 18. Propylene glycol-induced lactic acidosis in a patient receiving continuous infusion pentobarbital.
    Miller MA; Forni A; Yogaratnam D
    Ann Pharmacother; 2008 Oct; 42(10):1502-6. PubMed ID: 18698010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propylene glycol toxicity associated with lorazepam infusion in a patient receiving continuous veno-venous hemofiltration with dialysis.
    Al-Khafaji AH; Dewhirst WE; Manning HL
    Anesth Analg; 2002 Jun; 94(6):1583-5, table of contents. PubMed ID: 12032031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute tubular necrosis associated with propylene glycol from concomitant administration of intravenous lorazepam and trimethoprim-sulfamethoxazole.
    Hayman M; Seidl EC; Ali M; Malik K
    Pharmacotherapy; 2003 Sep; 23(9):1190-4. PubMed ID: 14524651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.